Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure.
Gespeichert in:
| Autor*in: |
Williams, Bryan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:386 ; year:2015 ; number:10008 ; day:21 ; month:11 ; pages:2059-2068 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0140-6736(15)00257-3 |
|---|
| Katalog-ID: |
ELV023233222 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV023233222 | ||
| 003 | DE-627 | ||
| 005 | 20230623165922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(15)00257-3 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015002000014.pica |
| 035 | |a (DE-627)ELV023233222 | ||
| 035 | |a (ELSEVIER)S0140-6736(15)00257-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |q VZ |
| 084 | |a 38.38 |2 bkl | ||
| 084 | |a 56.20 |2 bkl | ||
| 084 | |a 56.11 |2 bkl | ||
| 100 | 1 | |a Williams, Bryan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| 264 | 1 | |c 2015 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. | ||
| 700 | 1 | |a MacDonald, Thomas M |4 oth | |
| 700 | 1 | |a Morant, Steve |4 oth | |
| 700 | 1 | |a Webb, David J |4 oth | |
| 700 | 1 | |a Sever, Peter |4 oth | |
| 700 | 1 | |a McInnes, Gordon |4 oth | |
| 700 | 1 | |a Ford, Ian |4 oth | |
| 700 | 1 | |a Cruickshank, J Kennedy |4 oth | |
| 700 | 1 | |a Caulfield, Mark J |4 oth | |
| 700 | 1 | |a Salsbury, Jackie |4 oth | |
| 700 | 1 | |a Mackenzie, Isla |4 oth | |
| 700 | 1 | |a Padmanabhan, Sandosh |4 oth | |
| 700 | 1 | |a Brown, Morris J |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Dou, Chao ELSEVIER |t Effects of shape functions on flexural–torsional buckling of fixed circular arches |d 2013 |g London [u.a.] |w (DE-627)ELV007685041 |
| 773 | 1 | 8 | |g volume:386 |g year:2015 |g number:10008 |g day:21 |g month:11 |g pages:2059-2068 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(15)00257-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GEO | ||
| 936 | b | k | |a 38.38 |j Seismologie |q VZ |
| 936 | b | k | |a 56.20 |j Ingenieurgeologie |j Bodenmechanik |q VZ |
| 936 | b | k | |a 56.11 |j Baukonstruktion |q VZ |
| 951 | |a AR | ||
| 952 | |d 386 |j 2015 |e 10008 |b 21 |c 1121 |h 2059-2068 |g 10 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
b w bw |
|---|---|
| matchkey_str |
williamsbryanmacdonaldthomasmmorantsteve:2015----:prnlcoeesslcbbspooadoaoitdtriehotmlramnfrrgeitnhpresopt |
| hierarchy_sort_str |
2015 |
| bklnumber |
38.38 56.20 56.11 |
| publishDate |
2015 |
| allfields |
10.1016/S0140-6736(15)00257-3 doi GBVA2015002000014.pica (DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Williams, Bryan verfasserin aut Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. MacDonald, Thomas M oth Morant, Steve oth Webb, David J oth Sever, Peter oth McInnes, Gordon oth Ford, Ian oth Cruickshank, J Kennedy oth Caulfield, Mark J oth Salsbury, Jackie oth Mackenzie, Isla oth Padmanabhan, Sandosh oth Brown, Morris J oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 https://doi.org/10.1016/S0140-6736(15)00257-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 386 2015 10008 21 1121 2059-2068 10 045F 610 |
| spelling |
10.1016/S0140-6736(15)00257-3 doi GBVA2015002000014.pica (DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Williams, Bryan verfasserin aut Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. MacDonald, Thomas M oth Morant, Steve oth Webb, David J oth Sever, Peter oth McInnes, Gordon oth Ford, Ian oth Cruickshank, J Kennedy oth Caulfield, Mark J oth Salsbury, Jackie oth Mackenzie, Isla oth Padmanabhan, Sandosh oth Brown, Morris J oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 https://doi.org/10.1016/S0140-6736(15)00257-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 386 2015 10008 21 1121 2059-2068 10 045F 610 |
| allfields_unstemmed |
10.1016/S0140-6736(15)00257-3 doi GBVA2015002000014.pica (DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Williams, Bryan verfasserin aut Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. MacDonald, Thomas M oth Morant, Steve oth Webb, David J oth Sever, Peter oth McInnes, Gordon oth Ford, Ian oth Cruickshank, J Kennedy oth Caulfield, Mark J oth Salsbury, Jackie oth Mackenzie, Isla oth Padmanabhan, Sandosh oth Brown, Morris J oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 https://doi.org/10.1016/S0140-6736(15)00257-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 386 2015 10008 21 1121 2059-2068 10 045F 610 |
| allfieldsGer |
10.1016/S0140-6736(15)00257-3 doi GBVA2015002000014.pica (DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Williams, Bryan verfasserin aut Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. MacDonald, Thomas M oth Morant, Steve oth Webb, David J oth Sever, Peter oth McInnes, Gordon oth Ford, Ian oth Cruickshank, J Kennedy oth Caulfield, Mark J oth Salsbury, Jackie oth Mackenzie, Isla oth Padmanabhan, Sandosh oth Brown, Morris J oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 https://doi.org/10.1016/S0140-6736(15)00257-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 386 2015 10008 21 1121 2059-2068 10 045F 610 |
| allfieldsSound |
10.1016/S0140-6736(15)00257-3 doi GBVA2015002000014.pica (DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Williams, Bryan verfasserin aut Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. MacDonald, Thomas M oth Morant, Steve oth Webb, David J oth Sever, Peter oth McInnes, Gordon oth Ford, Ian oth Cruickshank, J Kennedy oth Caulfield, Mark J oth Salsbury, Jackie oth Mackenzie, Isla oth Padmanabhan, Sandosh oth Brown, Morris J oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 https://doi.org/10.1016/S0140-6736(15)00257-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 386 2015 10008 21 1121 2059-2068 10 045F 610 |
| language |
English |
| source |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 |
| sourceStr |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:386 year:2015 number:10008 day:21 month:11 pages:2059-2068 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Seismologie Ingenieurgeologie Bodenmechanik Baukonstruktion |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| authorswithroles_txt_mv |
Williams, Bryan @@aut@@ MacDonald, Thomas M @@oth@@ Morant, Steve @@oth@@ Webb, David J @@oth@@ Sever, Peter @@oth@@ McInnes, Gordon @@oth@@ Ford, Ian @@oth@@ Cruickshank, J Kennedy @@oth@@ Caulfield, Mark J @@oth@@ Salsbury, Jackie @@oth@@ Mackenzie, Isla @@oth@@ Padmanabhan, Sandosh @@oth@@ Brown, Morris J @@oth@@ |
| publishDateDaySort_date |
2015-01-21T00:00:00Z |
| hierarchy_top_id |
ELV007685041 |
| dewey-sort |
3610 |
| id |
ELV023233222 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023233222</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623165922.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(15)00257-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015002000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023233222</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(15)00257-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Williams, Bryan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">MacDonald, Thomas M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morant, Steve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Webb, David J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sever, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McInnes, Gordon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ford, Ian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cruickshank, J Kennedy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caulfield, Mark J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salsbury, Jackie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mackenzie, Isla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Padmanabhan, Sandosh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Morris J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:386</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:10008</subfield><subfield code="g">day:21</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:2059-2068</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(15)00257-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">386</subfield><subfield code="j">2015</subfield><subfield code="e">10008</subfield><subfield code="b">21</subfield><subfield code="c">1121</subfield><subfield code="h">2059-2068</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Williams, Bryan |
| spellingShingle |
Williams, Bryan ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| authorStr |
Williams, Bryan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007685041 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| topic |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_unstemmed |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_browse |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t m m tm tmm s m sm d j w dj djw p s ps g m gm i f if j k c jk jkc m j c mj mjc j s js i m im s p sp m j b mj mjb |
| hierarchy_parent_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| hierarchy_parent_id |
ELV007685041 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction |
| hierarchy_top_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007685041 |
| title |
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| ctrlnum |
(DE-627)ELV023233222 (ELSEVIER)S0140-6736(15)00257-3 |
| title_full |
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| author_sort |
Williams, Bryan |
| journal |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| journalStr |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
2059 |
| author_browse |
Williams, Bryan |
| container_volume |
386 |
| physical |
10 |
| class |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Williams, Bryan |
| doi_str_mv |
10.1016/S0140-6736(15)00257-3 |
| dewey-full |
610 690 |
| title_sort |
spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (pathway-2): a randomised, double-blind, crossover trial |
| title_auth |
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| abstract |
Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. |
| abstractGer |
Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. |
| abstract_unstemmed |
Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO |
| container_issue |
10008 |
| title_short |
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial |
| url |
https://doi.org/10.1016/S0140-6736(15)00257-3 |
| remote_bool |
true |
| author2 |
MacDonald, Thomas M Morant, Steve Webb, David J Sever, Peter McInnes, Gordon Ford, Ian Cruickshank, J Kennedy Caulfield, Mark J Salsbury, Jackie Mackenzie, Isla Padmanabhan, Sandosh Brown, Morris J |
| author2Str |
MacDonald, Thomas M Morant, Steve Webb, David J Sever, Peter McInnes, Gordon Ford, Ian Cruickshank, J Kennedy Caulfield, Mark J Salsbury, Jackie Mackenzie, Isla Padmanabhan, Sandosh Brown, Morris J |
| ppnlink |
ELV007685041 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0140-6736(15)00257-3 |
| up_date |
2024-07-06T18:21:31.284Z |
| _version_ |
1803854902760308736 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023233222</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623165922.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(15)00257-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015002000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023233222</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(15)00257-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Williams, Bryan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">MacDonald, Thomas M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morant, Steve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Webb, David J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sever, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McInnes, Gordon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ford, Ian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cruickshank, J Kennedy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caulfield, Mark J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salsbury, Jackie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mackenzie, Isla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Padmanabhan, Sandosh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Morris J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:386</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:10008</subfield><subfield code="g">day:21</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:2059-2068</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(15)00257-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">386</subfield><subfield code="j">2015</subfield><subfield code="e">10008</subfield><subfield code="b">21</subfield><subfield code="c">1121</subfield><subfield code="h">2059-2068</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3985224 |